• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与P1798小鼠淋巴肉瘤细胞中对致死性糖皮质激素作用产生抗性相关的蛋白质。

Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells.

作者信息

Nicholson M L, Voris B P, Young D A

出版信息

Cancer Res. 1981 Sep;41(9 Pt 1):3530-7.

PMID:6894886
Abstract

Two-dimensional gel electrophoresis was used to detect [35S]methionine-labeled newly synthesized proteins from corticosteroid-sensitive and corticosteroid-resistant P1798 mouse lymphosarcoma cells. When the protein patterns from corticosteroid-sensitive cells are compared with those from highly resistant cells, they are very similar except for seven changes. One of the most obvious changes is the appearance of a new protein with a molecular weight of about 36,000 in highly resistant cells. There are also four other proteins that increase in the resistant state, as well as two that decrease. The control experiments indicate that protein differences are present to approximately the same degree when the sensitive tumor is carried in adrenalectomized animals, suggesting that the protein differences are not induced by endogenous glucocorticoids. Other experiments show that the protein differences are neither components of the small amounts of fibrous tissue that are associated with the cells nor components of blood. These results suggest that resistance of the tumor cells to glucocorticoid killing in vivo could be related to the relative rates of synthesis of a few proteins.

摘要

二维凝胶电泳用于检测来自皮质类固醇敏感和皮质类固醇耐药的P1798小鼠淋巴肉瘤细胞的[35S]甲硫氨酸标记的新合成蛋白质。当将皮质类固醇敏感细胞的蛋白质模式与高度耐药细胞的蛋白质模式进行比较时,除了七个变化外,它们非常相似。最明显的变化之一是在高度耐药细胞中出现了一种分子量约为36,000的新蛋白质。还有其他四种蛋白质在耐药状态下增加,以及两种减少。对照实验表明,当在肾上腺切除的动物中携带敏感肿瘤时,蛋白质差异以大致相同的程度存在,这表明蛋白质差异不是由内源性糖皮质激素诱导的。其他实验表明,蛋白质差异既不是与细胞相关的少量纤维组织的成分,也不是血液的成分。这些结果表明,肿瘤细胞在体内对糖皮质激素杀伤的抗性可能与少数蛋白质的相对合成速率有关。

相似文献

1
Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells.与P1798小鼠淋巴肉瘤细胞中对致死性糖皮质激素作用产生抗性相关的蛋白质。
Cancer Res. 1981 Sep;41(9 Pt 1):3530-7.
2
Development of resistance to glucocorticoid hormones during rat thymus cell differentiation: proteins associated with emergence of the resistant state.大鼠胸腺细胞分化过程中糖皮质激素抗性的发展:与抗性状态出现相关的蛋白质
Cancer Res. 1983 Mar;43(3):1236-43.
3
Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.糖皮质激素体外对淋巴肉瘤P1798皮质类固醇敏感和耐药细胞系细胞核结构完整性的影响。
Cancer Res. 1978 Nov;38(11 Pt 1):3673-80.
4
Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake.糖皮质激素对淋巴细胞的致死作用独立于激素对钙摄取可能产生的影响。
J Supramol Struct. 1979;10(2):165-74. doi: 10.1002/jss.400100206.
5
Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.糖皮质激素受体与淋巴细胞肉瘤P1798的皮质醇敏感和耐药细胞系中的耐药机制
Cancer Res. 1974 Mar;34(3):621-6.
6
Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
J Natl Cancer Inst. 1980 Jan;64(1):55-62.
7
Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.皮质激素敏感和抗性淋巴肉瘤P1798的细胞膜唾液酸糖肽
Cancer Res. 1976 Jan;36(1):172-80.
8
Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.类固醇受体复合物与淋巴肉瘤P1798耐药及敏感细胞的核结合以及伴刀豆球蛋白A对受体水平的影响。
Cancer Res. 1977 Dec;37(12):4256-60.
9
Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.淋巴肉瘤P1798对小鼠皮下肿瘤DNA复制和生长的糖皮质激素效应。
J Natl Cancer Inst. 1980 Aug;65(2):477-83.
10
Selection and biologic properties of malignant variants of a murine lymphosarcoma.
J Natl Cancer Inst. 1978 Dec;61(6):1499-503.